Chemotherapy-induced Neutropenia

Biosimilar Agent to Pegfilgrastim Equally Safe, Efficacious for Neutropenia Prevention

Biosimilar Agent to Pegfilgrastim Equally Safe, Efficacious for Neutropenia Prevention

By

A biosimilar agent to pegfilgrastim was therapeutically equivalent and comparable to the reference agent in terms of efficacy and safety in the prevention of chemotherapy-induced neutropenia in patients with early stage breast cancer receiving chemotherapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs